This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
September 23-26, 2024
Hynes Convention CenterBoston, USA

Jing Liao
Director of Vector Development and Operations at Alexion Pharmaceuticals


Jing Liao is Director of Vector Development and Operations at Alexion Pharmaceuticals. Her team is focusing on plasmid optimization and cell line engineering to increase the yield of AAV production. She is also working on capsid engineering to improve the properties of the capsids. Dr. Liao was trained in Molecular, Cell and Stem cell Biology. She got her PhD from Institute of Biochemistry and Cell Biology (IBCB), Chinese Academy of Sciences (CAS) focusing on gene editing and reprogramming. She held a postdoctoral position at Harvard University studying epigenetic regulations.

Agenda Sessions

  • Navigating the Interplay between Advanced Vectors and Manufacturing Challenges